John Kokai-Kun | Vice President of Non-Clinical Affairs
Synthetic Biologics Inc

John Kokai-Kun, Vice President of Non-Clinical Affairs, Synthetic Biologics Inc

John F. Kokai-Kun, PhD
Vice President, Non-Clinical Affairs
John F. Kokai-Kun, PhD is currently Vice President of Non-Clinical Affairs for Synthetic Biologics, Inc. (Rockville, MD). He received his BS in Biochemistry from Juniata College in Huntingdon, PA and his PhD in Microbiology from the University of Pittsburgh, School of Medicine. He then served as a post-doctoral researcher at the Uniformed Services University of the Health Sciences in Bethesda, MD. Dr. Kokai-Kun has 20 years of experience in the drug development industry and has held positions with several biotechnology and pharmaceutical companies where his research and development efforts have focused primarily on anti-bacterial drugs and vaccines. He is also an Adjunct Assistant Professor of Microbiology and Immunology at the Uniformed Services University.

Appearances:



World Anti-Microbial Resistance Congress USA 2018 - Day 1 @ 12:35

Preventing Hospital Acquired Infections – review of clinical trials for Ribaxamase in the prevention of Clostridium difficile Infections

  • New product compound in development being designedto prevent deleterious effects of certain IV beta-lactam antibiotics, through gut microbiome protection
  • Potential to support successful antimicrobial stewardship programs (ASPs) by reducing Hospital Acquired Infections and potentially reducing Antimicrobial Resistance (AMR)
  • Why Ribaxamase has the potential to provide an additional strategic options for Infection Preventionist and Infection Control Specialists
last published: 16/Oct/18 20:05 GMT

back to speakers